Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Explainable AI in healthcare

explainable ai

Explainable AI in healthcare is the set of methods that show why a model flagged a case — which pixels, which labs, which features — instead of returning a bare score. It is not a second “what is AI in healthcare” explainer. That page is here.

A convolutional net can mark a nodule and not tell you which voxels drove the mark. A clinician who cannot check the mark will not use it. That is the trust problem. XAI is the attempt to put the evidence next to the score.

Transparency vs interpretability

  • Transparency is how the model is built: the architecture, the loss, the training data, the code path. You can read the blueprint.
  • Interpretability is why this case got this output: which features or pixels moved the score. You can check the mark against the image or the chart.

Both matter. A transparent linear model still needs the coefficients explained in clinical language. An opaque net can still be locally interpreted after the fact. Neither is a substitute for a signed report.

Post-hoc vs inherent

Post-hoc methods leave the trained model alone and explain one prediction (or the global feature ranking) afterwards. Two names you will actually see on imaging and tabular work:

  • LIME (Local Interpretable Model-agnostic Explanations; Ribeiro, Singh & Guestrin, KDD 2016). Perturb the input around one case, watch the black-box output change, fit a tiny local surrogate (usually a sparse linear model). The surrogate is the explanation for that case only. Paper: arXiv:1602.04938.
  • SHAP (SHapley Additive exPlanations; Lundberg & Lee, NeurIPS 2017). Assign each feature a credit for moving the prediction from a baseline, using Shapley values from cooperative game theory. Local and global. More expensive than LIME; more consistent across cases. Paper: arXiv:1705.07874.

Inherent models are readable without a detective layer. A decision tree is a yes/no path. A linear (or logistic) model is a weighted sum. You trade some peak accuracy on messy pixels for a path a reviewer can follow. That trade-off is real on some tasks and oversold on others — post-hoc methods exist so you can keep the accurate net and still ask “why this case.”

Technique When What you get Limit
LIME One case, any black box A local, sparse “these features mattered” Unstable if you re-run; local only
SHAP Local or global feature credit A signed contribution per feature Slow on large models; still an approximation
Decision tree You need a path a reviewer can walk The splits themselves Shallow trees underfit pixels
Linear / logistic Tabular risk scores, simple relationships A coefficient per variable Misses interactions unless you add them

Heat maps on images

On a scan the explanation is usually a saliency or class-activation map (Grad-CAM and cousins) overlaid on the MRI, CT, or X-ray. Warm pixels are the region that moved the score. The radiologist sees the region, not just a probability. That is the clinical form of post-hoc XAI — the same job as LIME/SHAP, drawn on anatomy.

A heat map can be wrong while the classification is right (and the reverse). It highlights correlation in the trained net, not a proven lesion. The reader still has to look at the original series. Detection is not diagnosis; an overlay is not a report. The generic diagnosis page is AI for medical diagnosis.

What it does not do

  • It does not automatically make the model fair. An explanation can show that zip code or scanner vendor drove the score. Fixing that is a dataset and training problem.
  • It does not always cost accuracy. LIME and SHAP sit on top of the existing net. Switching to a shallow tree to “be explainable” can cost accuracy. That is a model choice, not a law of XAI.
  • It is not a legal checkbox. The EU AI Act treats many medical systems as high-risk and asks for documentation and human oversight. FDA SaMD review asks for a file, not a LIME plot. An overlay helps a reviewer; it is not the clearance.
  • It is not a market forecast. Vendor CAGRs and “63% of hospitals” slides are not a reason to buy an explanation layer.

If the question is what AI in healthcare is at all — the stack, the imaging vs notes vs ops split, how a hospital actually starts — that is what is artificial intelligence in healthcare.

PYCAD builds the imaging side of this — custom pipelines and web DICOM viewers when the study, and the overlay, have to live in a clinic app. Case studies.

We build custom medical imaging platforms — advanced DICOM viewers, AI segmentation, and the clinical systems around them.

Get in Touch

Copyright © 2026 PYCAD. All Rights Reserved.